Clinical Trial

Smart Boot Use to Measure Offloading Adherence

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated January 16, 2026 (before its estimated March 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to help people with diabetes who develop neuropathic diabetic foot ulcers (DFUs). These ulcers, or sores, if left untreated can increase the chance of amputation. Part of the treatment is to have the person wear a diabetic shoe or boot to help their foot heal. Sometimes people don't wear the boot like they are told. The investigators want to compare three different kinds of diabetic boots to see if they can help make it easier for people to wear their boots as instructed. The investigators will look at three groups of participants: the first group will use removable offloading with reinforced education emphasizing continuous wear, including during rest and sleep, and not to remove it at any time. The second group will use removable offloading consistent with standard of care and receive education on recommended wear during walking or standing, with permission to remove the device during rest and sleep. The third group will use a smart removable offloading device that provides real-time adherence feedback via a smartwatch and smartphone, with additional personalized education informed by remotely monitored adherence data. The investigators will also be looking at how much physical activity, like walking, the participants do. And they will compare how well participants sleep and rate their quality of life in the three different boots. The investigators think that giving participants information about how much they are wearing their boot using readily available technology will help them to follow the doctor's directions better, and help their wounds heal faster.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2020-07-01; most recent amendment 2026-01-14.
Status change: Not Yet Recruiting → Recruiting 2021-10-27
Trial Details
NCT Number NCT04460573
Lead Sponsor University of Southern California
Collaborators: University of California, Los Angeles
Conditions Diabetic Foot Ulcer
Enrollment 210 participants
Start Date 2021-10-19
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-16